Bioabsorbable Stents Market Research and Forecast Report 2023-2028

1. Global Bioabsorbable Stents Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Bioabsorbable Stents Market Research Report: The latest report by IMARC, titled “Bioabsorbable Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " finds that the global bioabsorbable stents market size reached US$ 379.1 Million in 2022. Bioabsorbable stents (BRS) are advanced medical tools coated with an antiproliferative drug or gene that dissolves to restore vessel patency. It regulates the blood flow at branch points and limits the amount of blood to areas of the vascular network while also maintaining the flow. In addition, it reduces vessel irritation and inflammation, improves lesion imaging with cardiac computed tomography (CT), and facilitates repeat treatments to the same site. As a result, BRS is widely utilized in hospitals and cardiac centers across the globe. Request market/requestsample Free Sample Report: https://www.imarcgroup.com/bioabsorbable-stents-

4. Report Description and Highlights Report Description Global Bioabsorbable Stents Market Trends: The market is primarily driven by the growing prevalence of cardiovascular diseases caused by physical inactivity and excessive tobacco and alcohol consumption. In addition, the increasing preference for minimally invasive (MI) procedures, as they offer less postoperative pain, fewer complications, shortened hospital stay, and faster recovery times, is contributing to the market growth. Apart from this, the leading market players are conducting research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS), fixed-wire, and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. This, coupled with the increasing utilization of percutaneous coronary intervention (PCI) procedures for opening a blocked artery and carrying oxygen-rich blood through the body, is creating a positive market outlook across the globe. Looking forward, IMARC Group expects the market value to reach US$ 620.2 Million by 2028, exhibiting a CAGR of 8% during the forecast period (2023-2028). Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Breakup by Biomaterial: • Polymer-based Bioabsorbable Stents • Metal-based Bioabsorbable Stents Breakup by Absorption Rate: • Slow-Absorption Stents • Fast-Absorption Stents Breakup by Application: • Coronary Artery Disease • Peripheral Artery Disease Breakup by End User: • Hospitals • Cardiac Centers Breakup by Region: • North America

6. Report Description and Highlights Report Description • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others • Latin America

7. Report Description and Highlights Report Description • Brazil • Mexico • Others • Middle East and Africa

8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • Abbott Laboratories Arterius Limited B. Braun SE Biotronik SE & Co. KG Boston Scientific Corporation Elixir Medical Corporation Kyoto Medical Planning Co. Ltd. Lepu Medical Technology (Beijing) Co. Ltd. Meril Life Sciences Pvt. Ltd. Reva Medical LLC Terumo Corporation View Full Report with TOC & List of Figure: https://www.imarcgroup.com/bioabsorbable-stents- market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com